Research on Women's Health Beyond the Optimal Window

In this segment, Dr. Betty Murray (PhD) outlines the comprehensive monitoring approach her team uses for women who are beyond the reproductive "optimal window" and are undergoing therapy. She explains that while she does not prescribe medication, her role is to provide data‑driven analysis to support prescribers. The protocol begins with individualized assessment of each patient, focusing on both adherence to the therapeutic regimen and measurable therapeutic effects. Key monitoring tools include baseline functional qEEG and brain scans performed under cognitive load to detect early cognitive changes, regular sleep‑quality tracking using wearable devices to observe improvements in deep and REM sleep during therapy, and bone‑health evaluation through DEXA scans complemented by trabecular bone score (TBS) to assess fracture risk. Dr. Murray emphasizes the importance of early detection, the evolving reliability of consumer wearables, and the integration of these metrics to guide treatment decisions for women outside the optimal reproductive period.










